192 related articles for article (PubMed ID: 28924204)
1. Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Martin BP; Paudel R; Gnawali GR; Madani A; Puppo R; Landry V; Kremer L; Brodin P; Spilling CD; Cavalier JF; Canaan S
Sci Rep; 2017 Sep; 7(1):11751. PubMed ID: 28924204
[TBL] [Abstract][Full Text] [Related]
2. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
3. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
4. Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis.
Barelier S; Avellan R; Gnawali GR; Fourquet P; Roig-Zamboni V; Poncin I; Point V; Bourne Y; Audebert S; Camoin L; Spilling CD; Canaan S; Cavalier JF; Sulzenbacher G
FEBS J; 2023 Mar; 290(6):1563-1582. PubMed ID: 36197115
[TBL] [Abstract][Full Text] [Related]
5. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
[TBL] [Abstract][Full Text] [Related]
6. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of
Madani A; Ridenour JN; Martin BP; Paudel RR; Abdul Basir A; Le Moigne V; Herrmann JL; Audebert S; Camoin L; Kremer L; Spilling CD; Canaan S; Cavalier JF
ACS Infect Dis; 2019 Sep; 5(9):1597-1608. PubMed ID: 31299146
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.
Nguyen PC; Nguyen VS; Martin BP; Fourquet P; Camoin L; Spilling CD; Cavalier JF; Cambillau C; Canaan S
J Mol Biol; 2018 Dec; 430(24):5120-5136. PubMed ID: 30292819
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
9. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.
Chen D; Ma S; He L; Yuan P; She Z; Lu Y
Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032
[TBL] [Abstract][Full Text] [Related]
10. 1,4-diarylpiperazines and analogs as anti-tubercular agents: synthesis and biological evaluation.
Forge D; Cappoen D; Laurent J; Stanicki D; Mayence A; Huang TL; Verschaeve L; Huygen K; Vanden Eynde JJ
Eur J Med Chem; 2012 Mar; 49():95-101. PubMed ID: 22301215
[TBL] [Abstract][Full Text] [Related]
11. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
[TBL] [Abstract][Full Text] [Related]
12. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF
Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819
[TBL] [Abstract][Full Text] [Related]
13. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
14. Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
Choi SR; Britigan BE; Moran DM; Narayanasamy P
PLoS One; 2017; 12(5):e0177987. PubMed ID: 28542623
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach.
Ventura TL; Calixto SD; de Azevedo Abrahim-Vieira B; de Souza AM; Mello MV; Rodrigues CR; Soter de Mariz e Miranda L; Alves de Souza RO; Leal IC; Lasunskaia EB; Muzitano MF
Molecules; 2015 May; 20(5):8072-93. PubMed ID: 25951004
[TBL] [Abstract][Full Text] [Related]
16. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
[TBL] [Abstract][Full Text] [Related]
17. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production.
Mahmud HA; Seo H; Kim S; Islam MI; Nam KW; Cho HD; Song HY
BMC Complement Altern Med; 2017 May; 17(1):279. PubMed ID: 28545436
[TBL] [Abstract][Full Text] [Related]
19. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis.
Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N
Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment.
VanderVen BC; Fahey RJ; Lee W; Liu Y; Abramovitch RB; Memmott C; Crowe AM; Eltis LD; Perola E; Deininger DD; Wang T; Locher CP; Russell DG
PLoS Pathog; 2015 Feb; 11(2):e1004679. PubMed ID: 25675247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
